EGFR-HER2 inhibitor Erlotinib HCl, Purity ≥98%

Cat. No.: X23-10-ZQ1035

EGFR-HER2 inhibitor Erlotinib HCl, Purity ≥98%

Synonym: Erlotinib hydrochloride; 183319-69-9; erlotinib HCl; Tarceva; N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride; EGFR-HER2 inhibitor

  • MDL: MFCD07781272
  • CAS Number: 183319-69-9
  • Compound CID: 176871
Product Size
100 mg; 200 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Erlotinib HCl, soluble in warmed DMSO and insoluble in water and ethanol, is a potent and specific inhibitor of the tyrosine kinase activity of EGFR. It targets HER1/EGFR.
Molecular Weight
429.9
Molecular Formula
C22H23N3O4.HCl
Targets
HER1/EGFR: 2 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 4 mg/mL (9.3 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Erlotinib HCl is used to study EGFR inhibition in non-small cell lung cancer research.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0